Hello, everyone, and how are you today? Another pleasant morning is unfolding over the Pharmalot corporate campus, where the short people are sleeping in, the mascots are fertilizing the weeds and a cup of stimulation is brewing in the coffee kettle. An encouraging start to what is expected to be another busy day. We trust you can relate. After all, not everyone is on vacation, so time to get started. Here are a few tidbits to help you along. Hope your day goes well and do stay in touch...
Stem Cell Therapy For Autism To Be Tested In First Trial (Bloomberg News)
Allergan Signs Ophthalmic Drug Deal With Molecular Partners (Dow Jones)
J&J Wants Off Russian Monopoly List (RAPSI)
Sanofi Pulls Campath Ahead Of Possible Lemtrada Launch (Reuters)
Analysis Questions Data For WHO-Endorsed Bleeding Drug (Pharma Times)
Anti-Doping Agency Praises Pharma Help At Olympics (InPharma Technologist)
Glaxo To Close Indian API Plant (InPharma Technologist)
Halcyon Molecular Shuts Down (San Jose Business Journal)
Boehringer Faces Growing Number Of Lawsuits Over Pradaxa (The Tennessean)
Advocates Push Changes To South African Patent Law (Intellectual Property Watch)
J&J To Pay $600K To Settle First DePuy Hip Implant Suits (Bloomberg News)
Newer Psoriasis Drugs May Lower Heart Attack Risk (Health Day)
J&J's Weldon To Help Review JP Morgan's $5.8B Trading Loss (Bloomberg News)
EDITOR'S NOTE: Please check this post for updates during the day
tea kettle thx to mirahartford on flickr
5 Comments
http://www.jpmorganchase.com/corporate/About-JPMC/nominating-committee.htm
http://www.thecirt.org/index.html